CVS Health Corporation(CVS)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CVS | 112.49 B | 23.33x | 7.10% | 1.18% | $3.77 | 6.21% | 0.95x | 3.12% | $110.68 | $69.51 |
CI | 73.59 B | 11.68x | 6.70% | 2.27% | $23.85 | 16.76% | 0.74x | 2.29% | $308.48 | $234.20 |
LH | 25.30 B | 25.83x | 5.80% | 6.99% | $12.08 | 11.73% | 0.79x | 0.95% | $341.07 | $242.07 |
DGX | 25.06 B | 24.10x | 10.20% | 9.19% | $9.42 | 14.60% | 0.81x | 1.44% | $248.84 | $168.97 |
Peer Valuation & Performance Analysis
Peer group analysis for CVS Health Corporation (CVS) compared to its primary competitors (including CI, LH, DGX) reveals distinct metrics. CVS trades at a valuation premium compared to its competitors, with a P/E ratio of 23.3x versus the peer average of 20.5x (representing a 14% premium). This indicates that the market expects superior growth or commands a quality premium for CVS. In terms of growth, CVS's revenue growth of 7.1% is consistent with the peer average of 7.6%. Additionally, its net margin of 1.2% is below the peer average of 6.1%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CVS ranks #2 in P/E ratio, #2 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $87.05 | $89.93 | $87.00 | $87.95 | 8,467,900 | +1.76% |
| 2026-10-06 | $86.80 | $87.08 | $85.53 | $86.43 | 11,038,700 | -0.67% |
| 2026-10-05 | $86.69 | $87.51 | $86.33 | $87.01 | 12,009,700 | +0.64% |
| 2026-10-02 | $85.25 | $87.15 | $85.25 | $86.46 | 10,463,000 | +1.48% |
| 2026-10-01 | $85.48 | $86.26 | $84.23 | $85.20 | 6,560,100 | -0.57% |
| 2026-09-30 | $87.04 | $87.44 | $85.42 | $85.69 | 8,379,100 | -1.62% |
| 2026-09-29 | $87.20 | $87.56 | $86.36 | $87.10 | 7,152,300 | -0.85% |
| 2026-09-28 | $89.51 | $90.02 | $87.83 | $87.85 | 7,900,300 | -1.44% |
| 2026-09-25 | $85.35 | $89.35 | $84.70 | $89.13 | 15,767,300 | +4.80% |
| 2026-09-24 | $85.83 | $86.01 | $84.50 | $85.05 | 7,382,100 | -0.94% |
| 2026-09-23 | $86.70 | $86.98 | $85.67 | $85.86 | 7,313,600 | -1.42% |
| 2026-09-22 | $87.69 | $88.28 | $86.68 | $87.10 | 8,709,300 | -0.57% |
| 2026-09-21 | $88.73 | $88.91 | $87.19 | $87.60 | 10,135,700 | -1.40% |
| 2026-09-18 | $90.09 | $90.48 | $88.15 | $88.84 | 21,880,300 | -1.58% |
| 2026-09-17 | $92.00 | $92.14 | $90.17 | $90.27 | 7,433,000 | -1.58% |
Explore More Analysis for CVS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.